recovery ELISA PCSK9 Neutralization Rate

recovery ELISA PCSK9 Neutralization Rate | R777 | BioTeZ

Product Features:

Type: ELISA

Reactivity : Evolocumab and free PCSK9

Antigen : PCSK9

Detection Range : 0.2 – 24 µg/mL Evolocumab; PCSK9 in sample without Evolocumab: 40-800ng/ml; PCSK9 in sample with Evolocumab: 40-350ng/ml

Application : The unique recoveryELISA technology monitors parallel the free drug Evolocumab, the free antigen PCSK9 concentration and the neutralization rate of PCSK9 in patient sera during Evolocumab therapy.

Description : The unique recoveryELISA technology monitors parallel the free drug Evolocumab, the free antigen PCSK9 concentration and the neutralization rate of PCSK9 in patient sera during Evolocumab therapy. This next generation therapeutic drug monitoring tool can be used by diagnostic laboratories and medical doctors for research to find a personalized medication dose for each patient individually.

Research Area : Therapies and studies with Evolocumab, hypercholesterolemia, cardiovascular disease

Specificity : Evolocumab and PCSK9

Immunogen : N/A

Sensitivity : 4 ng/ml PCSK9; 0.02 µg/ml Evolocumab

Predicted Reactivity : Evolocumab and free PCSK9

Cross Reactivity : N/A

Minimum Shelf life time in months : 6 months

Storage Shipping Temp Min : ice pack to temperature >25°C

Storage Shipping Temp Max : 37°C

Storage Long Term : 2-8°C

Principle : Sandwich-ELISA

Components : microplate, buffers, antibody conjugate, standards, TMB reagent, stopping solution

Characteristics : Kit

Sample Type :

Format : 96 well microplate